Analyst Consensus ?
ConsensusBuy18 ratings
Bullish1055.6%
Neutral844.4%
Bearish00.0%
FN2 Earnings Intelligence
GE HealthCare Technologies Inc. complete analyst coverage
GE HealthCare Technologies Inc. (GEHC) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$69.56Current
$65Low
$85.88Average
$110High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| BTIG | Buy | Buy | Maintain | Jul 29, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 16, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 30, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Apr 30, 2026 |
| Goldman Sachs | Neutral | Buy | Downgrade | Apr 30, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Apr 30, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Apr 30, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Apr 30, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Apr 17, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Apr 13, 2026 |
| Stifel | Buy | Buy | Maintain | Feb 5, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Feb 5, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Jan 5, 2026 |
| Jefferies | Buy | Buy | Maintain | Dec 11, 2025 |
| Argus Research | Buy | Buy | Maintain | Apr 1, 2024 |
| Oppenheimer | Outperform | Outperform | Maintain | May 16, 2023 |
| Redburn Partners | Buy | Buy | Maintain | Jan 19, 2023 |
| Edward Jones | Hold | Hold | Maintain | Jan 4, 2023 |
Named analyst price targets
Upside is calculated against the persisted current price $69.56. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| BTIG | Analyst unavailable | $79 | $71.54 | +13.6% | Jul 29, 2026 |
| UBS | Analyst unavailable | $67 | $64.23 | -3.7% | Jul 16, 2026 |
| BTIG | Ryan Zimmerman | $75 | $64.7 | +7.8% | Jul 13, 2026 |
| BMO Capital | Analyst unavailable | $70 | $64.68 | +0.6% | Jul 8, 2026 |
| RBC Capital | Analyst unavailable | $80 | $60.64 | +15.0% | Jun 23, 2026 |
| UBS | Graham Doyle | $69 | $64.26 | -0.8% | May 21, 2026 |
| Evercore ISI | Analyst unavailable | $80 | $59.81 | +15.0% | Apr 30, 2026 |
| Oppenheimer | Suraj Kalia | $85 | $60.04 | +22.2% | Apr 30, 2026 |
| Barclays | Matt Miksic | $78 | $59.48 | +12.1% | Apr 30, 2026 |
| Goldman Sachs | David Roman | $65 | $59.48 | -6.6% | Apr 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $80 | $60.06 | +15.0% | Apr 29, 2026 |
| Piper Sandler | Analyst unavailable | $88 | $73.2 | +26.5% | Apr 17, 2026 |
| Mizuho Securities | Analyst unavailable | $90 | $72.69 | +29.4% | Apr 13, 2026 |
| Barclays | Analyst unavailable | $87 | $82.31 | +25.1% | Feb 6, 2026 |
| Stifel Nicolaus | Rick Wise | $98 | $82.63 | +40.9% | Feb 4, 2026 |
| Morgan Stanley | Analyst unavailable | $85 | $82.63 | +22.2% | Feb 4, 2026 |
| BTIG | Ryan Zimmerman | $91 | $83.7 | +30.8% | Feb 4, 2026 |
| Piper Sandler | Analyst unavailable | $94 | $78.78 | +35.1% | Jan 30, 2026 |
| UBS | Analyst unavailable | $77 | $85.3 | +10.7% | Jan 15, 2026 |
| Goldman Sachs | Analyst unavailable | $98 | $88.16 | +40.9% | Jan 9, 2026 |
| Stifel Nicolaus | Analyst unavailable | $95 | $86.73 | +36.6% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $95 | $84.2 | +36.6% | Jan 5, 2026 |
| Jefferies | Analyst unavailable | $105 | $85.54 | +50.9% | Dec 11, 2025 |
| Stifel Nicolaus | Rick Wise | $90 | $76.29 | +29.4% | Nov 21, 2025 |
| Wells Fargo | Larry Biegelsen | $87 | $77.38 | +25.1% | Oct 30, 2025 |
| BTIG | Analyst unavailable | $87 | $77.38 | +25.1% | Oct 29, 2025 |
| BTIG | Ryan Zimmerman | $89 | $71.01 | +27.9% | Oct 13, 2025 |
| Barclays | Analyst unavailable | $86 | $71.01 | +23.6% | Oct 13, 2025 |
| Morgan Stanley | Analyst unavailable | $74 | $74 | +6.4% | Sep 18, 2025 |
| UBS | Graham Doyle | $73 | $69.37 | +4.9% | May 5, 2025 |
| BTIG | Ryan Zimmerman | $95 | $64.39 | +36.6% | Apr 14, 2025 |
| Piper Sandler | Jason Bednar | $97 | $82.08 | +39.4% | Nov 15, 2024 |
| UBS | Graham Doyle | $74 | $93.01 | +6.4% | Sep 26, 2024 |
| Bank of America Securities | Craig Bijou | $97 | $90.62 | +39.4% | Sep 20, 2024 |
| BTIG | Ryan Zimmerman | $100 | $86.79 | +43.8% | Sep 18, 2024 |
| Goldman Sachs | David Roman | $87 | $78.45 | +25.1% | May 30, 2024 |
| Piper Sandler | Jason Bednar | $92 | $81.5 | +32.3% | May 21, 2024 |
| Mizuho Securities | Anthony Petrone | $105 | $77.74 | +50.9% | May 1, 2024 |
| Evercore ISI | Vijay Kumar | $96 | $76.24 | +38.0% | Apr 30, 2024 |
| Mizuho Securities | Anthony Petrone | $110 | $85.39 | +58.1% | Apr 11, 2024 |
| Argus Research | David Toung | $110 | $90.91 | +58.1% | Apr 1, 2024 |
| UBS | Graham Doyle | $88 | $83.17 | +26.5% | Feb 12, 2024 |
| Morgan Stanley | Patrick Wood | $76 | $77.17 | +9.3% | Jun 27, 2023 |
| Oppenheimer | Suraj Kalia | $97 | $77 | +39.4% | May 16, 2023 |
Track every rating change on GEHC the moment it posts. Free to start.
Start free